179 related articles for article (PubMed ID: 24946086)
1. Bioconjugates of rhizavidin with single domain antibodies as bifunctional immunoreagents.
Liu JL; Zabetakis D; Walper SA; Goldman ER; Anderson GP
J Immunol Methods; 2014 Sep; 411():37-42. PubMed ID: 24946086
[TBL] [Abstract][Full Text] [Related]
2. Stable, high-affinity streptavidin monomer for protein labeling and monovalent biotin detection.
Lim KH; Huang H; Pralle A; Park S
Biotechnol Bioeng; 2013 Jan; 110(1):57-67. PubMed ID: 22806584
[TBL] [Abstract][Full Text] [Related]
3. Comparison of single domain antibody immobilization strategies evaluated by surface plasmon resonance.
Walper SA; Brozozog Lee PA; Goldman ER; Anderson GP
J Immunol Methods; 2013 Feb; 388(1-2):68-77. PubMed ID: 23261918
[TBL] [Abstract][Full Text] [Related]
4. Single-chain antibody streptavidin fusions: tetrameric bifunctional scFv-complexes with biotin binding activity and enhanced affinity to antigen.
Kipriyanov SM; Breitling F; Little M; Dübel S
Hum Antibodies Hybridomas; 1995; 6(3):93-101. PubMed ID: 8597629
[TBL] [Abstract][Full Text] [Related]
5. Conjugation of biotin-coated luminescent quantum dots with single domain antibody-rhizavidin fusions.
Liu JL; Walper SA; Turner KB; Lee AB; Medintz IL; Susumu K; Oh E; Zabetakis D; Goldman ER; Anderson GP
Biotechnol Rep (Amst); 2016 Jun; 10():56-65. PubMed ID: 28352525
[TBL] [Abstract][Full Text] [Related]
6. Linear gene fusions of antibody fragments with streptavidin can be linked to biotin labelled secondary molecules to form bispecific reagents.
Pearce LA; Oddie GW; Coia G; Kortt AA; Hudson PJ; Lilley GG
Biochem Mol Biol Int; 1997 Sep; 42(6):1179-88. PubMed ID: 9305536
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of bis-biotin-containing reagents for applications utilizing monoclonal antibody-based pretargeting systems with streptavidin mutants.
Wilbur DS; Park SI; Chyan MK; Wan F; Hamlin DK; Shenoi J; Lin Y; Wilbur SM; Buchegger F; Pantelias A; Pagel JM; Press OW
Bioconjug Chem; 2010 Jul; 21(7):1225-38. PubMed ID: 20597486
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of anti-tenascin monoclonal antibody-streptavidin conjugates for pretargeting applications.
Foulon CF; Bigner DD; Zalutsky MR
Bioconjug Chem; 1999; 10(5):867-76. PubMed ID: 10502355
[TBL] [Abstract][Full Text] [Related]
9. Rhizavidin from Rhizobium etli: the first natural dimer in the avidin protein family.
Helppolainen SH; Nurminen KP; Määttä JA; Halling KK; Slotte JP; Huhtala T; Liimatainen T; Ylä-Herttuala S; Airenne KJ; Närvänen A; Jänis J; Vainiotalo P; Valjakka J; Kulomaa MS; Nordlund HR
Biochem J; 2007 Aug; 405(3):397-405. PubMed ID: 17447892
[TBL] [Abstract][Full Text] [Related]
10. Effect of linkers on immobilization of scFvs with biotin-streptavidin interaction.
Ikonomova SP; Le MT; Kalla N; Karlsson AJ
Biotechnol Appl Biochem; 2018 Jul; 65(4):580-585. PubMed ID: 29377386
[TBL] [Abstract][Full Text] [Related]
11. A tetravalent single-chain antibody-streptavidin fusion protein for pretargeted lymphoma therapy.
Schultz J; Lin Y; Sanderson J; Zuo Y; Stone D; Mallett R; Wilbert S; Axworthy D
Cancer Res; 2000 Dec; 60(23):6663-9. PubMed ID: 11118050
[TBL] [Abstract][Full Text] [Related]
12. Immunodiagnostic reagents using llama single domain antibody-alkaline phosphatase fusion proteins.
Swain MD; Anderson GP; Serrano-González J; Liu JL; Zabetakis D; Goldman ER
Anal Biochem; 2011 Oct; 417(2):188-94. PubMed ID: 21756867
[TBL] [Abstract][Full Text] [Related]
13. A genetically engineered anti-CD45 single-chain antibody-streptavidin fusion protein for pretargeted radioimmunotherapy of hematologic malignancies.
Lin Y; Pagel JM; Axworthy D; Pantelias A; Hedin N; Press OW
Cancer Res; 2006 Apr; 66(7):3884-92. PubMed ID: 16585217
[TBL] [Abstract][Full Text] [Related]
14. Design of a bifunctional fusion protein for ovarian cancer drug delivery: single-chain anti-CA125 core-streptavidin fusion protein.
Wang WW; Das D; McQuarrie SA; Suresh MR
Eur J Pharm Biopharm; 2007 Mar; 65(3):398-405. PubMed ID: 17257818
[TBL] [Abstract][Full Text] [Related]
15. In vivo biotinylated recombinant antibodies: construction, characterization, and application of a bifunctional Fab-BCCP fusion protein produced in Escherichia coli.
Weiss E; Chatellier J; Orfanoudakis G
Protein Expr Purif; 1994 Oct; 5(5):509-17. PubMed ID: 7827508
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of rhizavidin: insights into the enigmatic high-affinity interaction of an innate biotin-binding protein dimer.
Meir A; Helppolainen SH; Podoly E; Nordlund HR; Hytönen VP; Määttä JA; Wilchek M; Bayer EA; Kulomaa MS; Livnah O
J Mol Biol; 2009 Feb; 386(2):379-90. PubMed ID: 19111749
[TBL] [Abstract][Full Text] [Related]
17. [The biotin-thyroxin conjugate as a bifunctional ligand of binding proteins].
Novakovskiĭ ME; Vashkevich II; Sviridov OV
Bioorg Khim; 2009; 35(2):178-91. PubMed ID: 19537169
[TBL] [Abstract][Full Text] [Related]
18. Applying biotin-streptavidin binding for iscom (immunostimulating complex) association of recombinant immunogens.
Wikman M; Friedman M; Pinitkiatisakul S; Hemphill A; Lövgren-Bengtsson K; Lundén A; Ståhl S
Biotechnol Appl Biochem; 2005 Apr; 41(Pt 2):163-74. PubMed ID: 15296488
[TBL] [Abstract][Full Text] [Related]
19. A simple and robust approach to immobilization of antibody fragments.
Ikonomova SP; He Z; Karlsson AJ
J Immunol Methods; 2016 Aug; 435():7-16. PubMed ID: 27142477
[TBL] [Abstract][Full Text] [Related]
20. Autodisplay of streptavidin.
Park M; Jose J; Thömmes S; Kim JI; Kang MJ; Pyun JC
Enzyme Microb Technol; 2011 Apr; 48(4-5):307-11. PubMed ID: 22112942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
